Disponibile in EN | FR
Caroline Kant
Storia edita da un curatore
Questo articolo è apparso per la prima volta su Virgin.com

While working at Merck Serono in the research and development (R&D) knowledge management department, Caroline Kant discovered many drugs sitting on the company’s shelves, waiting to be researched on, and which could become part of a much needed solution to treat rare diseases.

CONTINUA A LEGGERE

Approfondimenti di Ashoka

While working at Merck Serono in the research and development (R&D) knowledge management department, Caroline Kant discovered many drugs sitting on the company’s shelves, waiting to be researched on, and which could become part of a much needed solution to treat rare diseases. As a mother of a child affected by an unidentified rare disease, Caroline decided to devote her professional life to giving a chance to these unexplored treatments that could be life-changing to so many other children affected by diseases worldwide.

Argomenti correlatiSalute e Fitness Ricerca medica

Autore

Caroline is interested in inclusive finance, impact evaluation and innovative market-based interventions aimed at reducing poverty and inequality. Caroline started her career in finance at General Electric where she worked for four years. More recently, she worked in the Strategic Initiatives team at Gavi, the Vaccine Alliance, and held short-term positions at UNDP in Vietnam and Grameen Bank in Bangladesh. Caroline has also been involved in her free time in entrepreneurial activities to promote economic development. In 2004, she implemented a scholarship program for Dalits in India and since 2012, she co-founded Maloulie, a baby clothing company made in Peru. Caroline holds a double Master in Management from ESCP Europe and a Master of Public Administration from Columbia University.

Altre info per te